{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T05:10:03Z","timestamp":1729314603045,"version":"3.27.0"},"reference-count":30,"publisher":"The Fukushima Society of Medical Science","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FJMS","Fukushima J. Med. Sci."],"published-print":{"date-parts":[[2024]]},"DOI":"10.5387\/fms.2023-21","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T22:10:54Z","timestamp":1727993454000},"page":"175-182","source":"Crossref","is-referenced-by-count":0,"title":["Seven cases illustrating difficulties in the treatment of MPO-ANCA-positive refractory otitis media"],"prefix":"10.5387","volume":"70","author":[{"given":"Koshi","family":"Otsuki","sequence":"first","affiliation":[{"name":"Otsuki ENT Clinic"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuyoshi","family":"Imaizumi","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigeyuki","family":"Murono","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3342","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kallenberg CG, Heeringa P, Stegeman CA, <i>et al.<\/i>\u3000Mechanism of Disease:pathogenesis and treatment of ANCA-associated vasculitides.\u3000Nat Clin Pract Rheumatol, <b>2<\/b>:661-670, 2006.","DOI":"10.1038\/ncprheum0355"},{"key":"2","unstructured":"2. Harigai M, Narita I, Sudo T, <i>et al.<\/i>\u3000anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) Practice Guideline 2023 (In Japanese).\u3000shindan to chiryosya, ISBN 978478782573, 2023."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Jennette JC.\u3000Overview of the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.\u3000Clin Exp Nephrol, <b>17<\/b>(5):603-606, 2013.","DOI":"10.1007\/s10157-013-0869-6"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nakamaru Y, Takagi D, Oridate N, <i>et al.<\/i>\u3000Otolaryngologic Manifestations of Antineutrophil Cytoplasmic Antibody Associated Vasculitis.\u3000Otolaryngology Head and Neck Surgery, <b>146<\/b>:119-121, 2012.","DOI":"10.1177\/0194599811424044"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Balow JE.\u3000Renal vasculitis.\u3000Curr Opin Nephrol Hypertens<i>, <\/i><b>2<\/b>:231-7, 1993.","DOI":"10.1097\/00041552-199303000-00009"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kallenberg CG.\u3000Pathogenesis of ANCA-associated vasculitides.\u3000Ann Rheum Dis<i>,<\/i> <b>70<\/b>:i59-63, 2011.","DOI":"10.1136\/ard.2010.138024"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kallenberg CG.\u3000Anti-neutrophil cytoplasmic antibodies:current diagnostic and pathophysiological potential.\u3000Kidney Int<i>, <\/i><b>46<\/b>:1-15, 1994.","DOI":"10.1038\/ki.1994.239"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Savige J, Gillis D, Benson E, <i>et al.<\/i>\u3000International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies (ANCA).\u3000Am J Clin Pathol, <b>111<\/b>:507-513, 1999.","DOI":"10.1093\/ajcp\/111.4.507"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Rao JK, Weinberger M, Oddone EZ, <i>et al.<\/i>\u3000The role of antineutrophil cytoplasmic antibody testing in the diagnosis of Wegener granulomatosis.\u3000Ann Intern Med<i>, <\/i><b>123<\/b>:925-932, 1995.","DOI":"10.7326\/0003-4819-123-12-199512150-00005"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Hagen EC, Daha MR, Hermans J, <i>et al.<\/i>\u3000Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis.\u3000EC\/BCR project for ANCA assay standardization.\u3000Kidney Int<i>, <\/i><b>53<\/b>:743-753, 1998.","DOI":"10.1046\/j.1523-1755.1998.00807.x"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Kobayashi S, Fujimoto S.\u3000Epidemiology of vasculitides:differences between Japan, Europe and North America.\u3000Clin Exp Nephrol<i>, <\/i><b>17<\/b>:611-614, 2013.","DOI":"10.1007\/s10157-013-0813-9"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Numano F.\u3000Differences in clinical presentation and outcome in different countries for Takayasu\u2019s arteritis.\u3000Curr Opin Rheumatol, <b>9<\/b>:12-15, 1997.","DOI":"10.1097\/00002281-199701000-00003"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Watanabe K, Tani Y, Kimura H, <i>et al.<\/i>\u3000Clinical Outcomes of Japanese MPO-ANCA-related Nephritis: Significance of initial renal death for survival.\u3000Intern Med, 1969-1976, 2012.","DOI":"10.2169\/internalmedicine.51.7727"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Fujimoto S, Watts RA, Kobayashi S, <i>et al.<\/i>\u3000Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K.\u3000Rheumatology (Oxford), <b>50<\/b>:1916-1920, 2011.","DOI":"10.1093\/rheumatology\/ker205"},{"key":"15","unstructured":"15. Hashimoto H.\u3000Study on clinical epidemiology investigation between Japan and Europe of the ANCA-related vasculitis and diagnostic agent and therapy development 2007 (in Japanese)."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Takagi D, Nakamaru Y, Maguchi S, <i>et al.<\/i>\u3000Otologic manifestations of Wegener\u2019s granulomatosis.\u3000Laryngoscope, <b>112<\/b>:1684-1690, 2002.","DOI":"10.1097\/00005537-200209000-00029"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Fauci AS, Haynes BF, Katz P, <i>et al.<\/i>\u3000Wegener\u2019s granulomatosis:prospective clinical and therapeutic experience with 85 patients for 21 years.\u3000Ann Intern Med, <b>98<\/b>:76-85, 1983.","DOI":"10.7326\/0003-4819-98-1-76"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Nicklasson B, Stangeland N.\u3000Wegener\u2019s granulomatosis presenting as otitis media:J Laryngol Otol, <b>96<\/b>:277-280, 1982.","DOI":"10.1017\/S0022215100092501"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hoffman GS, Kerr GS, Leavitt RY, <i>et al.<\/i>\u3000Wegener granulomatosis:an analysis of 158 patients.\u3000Ann Intern Med, <b>116<\/b>:488-498, 1992.","DOI":"10.7326\/0003-4819-116-6-488"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Devaney KO, Travis WD, Hoffman GS, <i>et al.<\/i>\u3000Interpretation of head and neck biopsies in Wegener\u2019s granulomatosis.\u3000A pathologic study of 126 biopsies in 70 patients.\u3000Am J Surg Pathol, <b>14<\/b>: 555-564, 1990.","DOI":"10.1097\/00000478-199006000-00006"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Travis WD, Hoffman GS, Leavitt RY, <i>et al.<\/i>\u3000Surgical pathology of the lung in Wegener\u2019s granulo\u00admatosis.\u3000Review of 87 open lung biopsies from 67 patients.\u3000Am J Surg Pathol, <b>15<\/b>:315-333, 1991.","DOI":"10.1097\/00000478-199104000-00001"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoshida N, Hara M, Hasegawa M, <i>et al.<\/i>\u3000Reversible Cochlear Function With ANCA-Associated Vasculitis Initially Diagnosed by Otologic Symptoms.\u3000Otology &amp; Neurotology, <b>35<\/b>:114-120, 2013.","DOI":"10.1097\/MAO.0000000000000175"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. McDonald TJ, DeRemee RA.\u3000Wegener\u2019s granulomatosis.\u3000Laryngoscope, <b>93<\/b>:220-231, 1983.","DOI":"10.1288\/00005537-198302000-00020"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. McDonald TJ, DeRemee RA, Weiland LH, <i>et al.<\/i>\u3000Wegener\u2019s granulomatosis and polymorphic reticulosis-two disease or one?\u3000Arch Otolaryngol, <b>107<\/b>:141-144, 1981.","DOI":"10.1001\/archotol.1981.00790390007003"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Okamura H, Ohtani I, Anzai T, <i>et al.<\/i>\u3000The hearing loss in Wegener\u2019s granulomatosis:relationship between hearing loss and serum ANCA.\u3000Auris Nasus Larynx, <b>19<\/b>:1-6, 1992.","DOI":"10.1016\/S0385-8146(12)80195-7"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Ohtani I, Baba Y, Suzuki C, <i>et al.<\/i>\u3000Temporal bone pathology in Wegener\u2019s granulomatosis.\u3000Fukushima J Med Sci, <b>46<\/b>:31-39, 2000.","DOI":"10.5387\/fms.46.31"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Harabuchi Y, Kishibe K, Tateyama K, <i>et al.<\/i>\u3000Clinical features and treatment outcomes of otitis media with antineutronphil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV):a retrospective analysis of 235 patients from a nationwide survey in Japan.\u3000Mod Rheumatol, <b>27<\/b>(1):87-94, 2017.","DOI":"10.1080\/14397595.2016.1177926"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Harabuchi Y, Kishibe K, Tateyama K, <i>et al.<\/i>\u3000Clinical characteristics, the diagnostic criteria and management recommendation of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV) proposed by Japan Otological Society.\u3000Auris Nasus Larynx, <b>48<\/b>:2-14, 2021.","DOI":"10.1016\/j.anl.2020.07.004"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Yashiro-Furuya, <i>et al.<\/i>\u3000Outcome of rituximab treatment in Japanese patients with ANCA-associated vasculitis in daily clinical practice:A two-centre study in Fukushima, Japan.\u3000Mod Rheumatol, <b>33<\/b>(2):352-359, 2023.","DOI":"10.1093\/mr\/roac027"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Kusumoto S, Tanaka Y, Mizokami M, <i>et al.<\/i>\u3000Reactivation of hepatitis B virus following systemic chemotherapy for malignant lymphoma.\u3000Int J Hematol, <b>90<\/b>:13-23, 2009.","DOI":"10.1007\/s12185-009-0359-5"}],"container-title":["FUKUSHIMA JOURNAL OF MEDICAL SCIENCE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/70\/4\/70_2023-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,19]],"date-time":"2024-10-19T04:47:17Z","timestamp":1729313237000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/fms\/70\/4\/70_2023-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.5387\/fms.2023-21","relation":{},"ISSN":["0016-2590","2185-4610"],"issn-type":[{"type":"print","value":"0016-2590"},{"type":"electronic","value":"2185-4610"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"2023-21"}}